| MOQ: | 1 Sets |
| Price: | 10000 USD |
| Delivery Period: | 2 months |
| Payment Method: | L/C,T/T |
| Supply Capacity: | 200 sets / days |
What Is a Single-Use Reactor? Disposable Technology, Benefits & Applications
Answering the core question: What is a single-use reactor, and what advantages does disposable bioprocessing technology offer over traditional stainless steel reactors? A single-use reactor (SUR) is a bioprocessing vessel in which the product-contacting components (flexible film bag, agitation impeller, sensors, and tubing) are disposable, gamma-irradiated (25-50 kGy) polymer assemblies installed in a reusable stainless steel support structure. The disposable bags are manufactured from USP Class VI-certified multilayer films (typically PE contact layer, EVA barrier, and PA/EVOH gas barrier) validated per USP <665> and <1031> for extractables and leachables. Single-use reactors eliminate clean-in-place (CIP) and sterilize-in-place (SIP) validation, reduce changeover time from 2-3 weeks to 4-8 hours, eliminate cross-contamination risk, and reduce capital expenditure by 30-40% compared to stainless steel facilities. They are the standard in cell therapy (CAR-T), vaccine, clinical trial, and flexible multi-product biomanufacturing, with cell densities reaching 20x10^6 cells/mL in perfusion mode.
1. Core Design Principles of Single-Use Reactors
Single-use reactor design integrates four disposable technology principles:
2. Major Types and Applications of Single-Use Reactors
Single-use reactors are categorized by bioprocess application and cell line type:
Single-Use vs. Stainless Steel Reactor Comparison Matrix
| Parameter | Single-Use Reactor | Stainless Steel Reactor | Advantage |
|---|---|---|---|
| Changeover Time | 4-8 hours (bag swap + setup) | 2-3 weeks (CIP/SIP + batch record) | Single-use: 50-80x faster; enables multi-product flexible manufacturing |
| Capex | 30-40% lower (no CIP/SIP skids, less utilities) | 100% baseline (CIP/SIP skids, steam, WFI distribution) | Single-use: lower initial investment; smaller facility footprint |
| Validation | No CIP/SIP validation; extractables per USP <665> | Extensive CIP/SIP validation (3 consecutive batches) | Single-use: reduced validation effort and documentation |
Frequently Asked Questions (FAQ)
Q: What is the gamma irradiation dose used to sterilize single-use reactor bags?
A: Single-use reactor bags are sterilized by gamma irradiation (Cobalt-60) at a minimum dose of 25 kGy per ISO 11137, with typical dose ranges of 25-50 kGy. This achieves a sterility assurance level (SAL) of 10^-6. Dose mapping verifies uniform distribution throughout the packaged assembly, with dose ratio (max/min) below 1.5. The polyethylene contact layer and EVA barrier layer are gamma-stable, but material qualification is required because gamma causes chain scission or crosslinking that can affect mechanical properties and extractables profiles.
Q: What are extractables and leachables studies for single-use reactor bags?
A: Extractables are compounds that can be forced from the bag material under exaggerated conditions (elevated temperature, extended contact time, aggressive solvents including 50% ethanol, 0.1 M NaOH, and WFI) per USP <665>. Leachables are the subset of extractables that actually migrate into the process fluid under actual manufacturing conditions, quantified per USP <1031> and compared against ICH Q3D elemental impurity limits. Studies must demonstrate that no leachable exceeds 30% of the permitted daily exposure (PDE) for each element.
Q: How does the changeover time of a single-use reactor compare to stainless steel?
A: Single-use reactor changeover requires 4-8 hours (bag removal, new bag installation, sensor calibration, and pre-use integrity testing). Stainless steel reactor changeover requires 2-3 weeks for CIP (multi-step chemical cleaning with validation sampling), SIP (3 consecutive steam sterilization cycles with biological indicators), and batch record documentation. The 50-80x faster changeover enables multi-product manufacturing with minimal campaign overlap, which is essential for CDMO flexibility, cell therapy patient-specific production, and clinical trial material manufacturing.
Q: What cell densities can single-use bioreactors achieve?
A: Stirred-tank single-use bioreactors (SUBs) achieve CHO cell densities of 15-20x10^6 cells/mL in fed-batch mode and 50-100x10^6 cells/mL in perfusion mode with alternating tangential flow (ATF) filtration. Rocking motion bioreactors achieve lower densities (5-15x10^6 cells/mL) due to lower oxygen transfer (k_La = 3-8 /h vs 15-30 /h for stirred-tank). The limiting factor in single-use systems is gas-liquid mass transfer, as sparging rates above 0.1 vvm can cause excessive foaming and potential bag overpressure, requiring antifoam strategies.